CN1840524A - Process for preparing fudosteine - Google Patents

Process for preparing fudosteine Download PDF

Info

Publication number
CN1840524A
CN1840524A CN 200510059733 CN200510059733A CN1840524A CN 1840524 A CN1840524 A CN 1840524A CN 200510059733 CN200510059733 CN 200510059733 CN 200510059733 A CN200510059733 A CN 200510059733A CN 1840524 A CN1840524 A CN 1840524A
Authority
CN
China
Prior art keywords
reaction
fudosteine
formula
compound
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510059733
Other languages
Chinese (zh)
Other versions
CN100543014C (en
Inventor
曲峰
李彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing D-Venturepharm Technology Development Co., Ltd.
Original Assignee
BEIJING D-VENTURE PHARM T CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING D-VENTURE PHARM T CORP filed Critical BEIJING D-VENTURE PHARM T CORP
Priority to CN 200510059733 priority Critical patent/CN100543014C/en
Publication of CN1840524A publication Critical patent/CN1840524A/en
Application granted granted Critical
Publication of CN100543014C publication Critical patent/CN100543014C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a process for preparing Fudosteine, which has the chemical structural formula (I) disclosed in the specification. The Fudosteine can be used as the medicament for relieving cough and expectorant.

Description

A kind of preparation method of Fudosteine
Invention field
The present invention relates to the preparation method of Fudosteine, above-claimed cpd can be used as antibechic, apophlegmatisant.
Background of invention
Fudosteine (chemical name: 3-hydroxypropyl sulfo-L-Ala), have the following formula structure:
Fudosteine can effectively reduce the mucous secretion of chronic respiratory disease patient, thereby has good antibechic, the effect of reducing phlegm.
At present the method for synthetic Fudosteine is a starting raw material with the L-halfcystine all, is prepared with different branched building block butt joint, and disclosed synthetic method about Fudosteine is as follows:
See document Biochemistry 1991 by the method that L-halfcystine and 3-bromo-1 propyl alcohol are prepared under alkaline catalysis, 30,4078~4081, this method comprises: a) L-halfcystine and 3-bromo-1 propyl alcohol are put in the strong alkali aqueous solution such as sodium hydroxide; B) drip ethanol to obtaining homogeneous phase solution; C) stirring reaction spends the night; D) filter, regulate pH with strong acid; E) concentrating under reduced pressure; D) recrystallization obtains the product Fudosteine.There is following shortcoming in this method: the reaction times is long, and relates to materials such as bromide, strong acid, highly basic in the reaction, and is bigger to structure deteriorate, and because the existence of bromide has serious environmental issue, cause cost to raise.
See patent JP8119932 by the method that L-halfcystine and vinyl carbinol are prepared under free radical catalysts such as superoxide or high light catalysis, this method comprises: a) L-halfcystine and vinyl carbinol are added to the water; B) add free radical catalyst such as Sodium Persulfate or carry out strong illumination; C) add water-miscible organic solvent after reaction finishes and separate out solid, obtain the product Fudosteine.There is following shortcoming in this method: because employed catalyzer is salt, and the polarity of finished product Fudosteine is bigger, and the solvability in the aqueous solution is good, is difficult for finished product is well separated with catalyzer, thereby cause residual salts substances in the finished product, second-rate.With L-halfcystine and vinyl carbinol under strong illumination catalysis to being bonded into the method for Fudosteine, because strong illumination is difficult for realizing large-scale industrial production to the having relatively high expectations of production unit.Therefore be necessary to seek one more economically, the preparation method of efficient and environmental protection.
The method of catalysis free radical reaction commonly used roughly has three kinds, be that peroxide catalyst carries out catalysis, light-initiated or thermal initiation, we attempted peroxide catalyzed and light-initiated after, the thermal initiation test has been carried out in this reaction again, the result has obtained good reaction effect.
Goal of the invention
The preparation method who the purpose of this invention is to provide the Fudosteine of a kind of economy, efficient and environmental protection.
Summary of the invention
The preparation method of the Fudosteine that this patent provides comprises: in the aqueous solution L-halfcystine is mixed with vinyl carbinol, cause by heating, obtain the finished product Fudosteine.
Feature of the present invention is, avoided use strong acid or highly basic and bromide to react, and avoided strong acid, alkaline neutralization reaction in the process of aftertreatment equally, helps the protection to physical environment in suitability for industrialized production in the future; Avoided the use high light that reaction is caused, reduced requirement production unit; Avoided the use of free radical catalysts such as superoxide, thereby avoided in finished product, introducing salts substances, helped improving the quality of products.
Of the present invention open in detail:
In the aqueous solution, with the mol ratio of compound shown in compound shown in the formula (I) and the formula (II) with 1: 1~1: 3, preferred 1: 2 mol ratio is mixed, Heating temperature is 40 ℃~80 ℃, carry out addition under preferred 50~60 ℃, in reaction mixture, add water-miscible organic solvent at last and separate out precipitation, obtain Fudosteine.
Following embodiment is to describe in detail the present invention, and unrestricted the present invention.
The bibliographic reference example
Biochemistry?1991,30,4078~4081:P.4079
2.37 gram 3-bromo-1-propyl alcohol are joined in the mixed solution of 2.68 gram cysteine hydrochlorides and 10 milliliters of aqueous sodium hydroxide solutions (3.4M), drip ethanol to obtaining homogeneous system, stirring is spent the night.The small amount of precipitate that generates is filtered out, and filtrate is 5 with aqueous hydrochloric acid (5M) regulation system pH value, underpressure distillation, and gained solid water-ethanol mixed solvent recrystallization gets 0.6 gram product.
JP8119932 embodiment 1:
2.0g (16.5mmol) L-halfcystine is dissolved in 20ml water, adds 1.95 gram (33mmol) vinyl carbinols, stirring at room.Add the 200mg Potassium Persulfate, continue to stir 15 minutes.Reaction removes solvent under reduced pressure after finishing, and adds ethanol (25%) in residue, the filtering insolubles, and filtrate decompression concentrates, and residue water-ethanol system recrystallization gets the 2.5g clear crystal, yield 85%.
JP8119932 embodiment 2:
2.0g (16.5mmol) L-halfcystine is dissolved in 20ml water, adds 1.95 gram (33mmol) vinyl carbinols, stirring at room.Add 200mg iron protochloride and 200mg peroxy-disulfuric acid ammonia, continue to stir 15 minutes.Reaction removes solvent under reduced pressure after finishing, and adds ethanol (25%) in residue, the filtering insolubles, and filtrate decompression concentrates, and residue water-ethanol system recrystallization gets the 2.3g clear crystal, yield 80%.
JP8119932 embodiment 3:
2.0g (16.5mmol) L-halfcystine is dissolved in 20ml water, adds 1.95 gram (33mmol) vinyl carbinols, stirring at room.Add 200mg iron protochloride and 200mg peroxy-disulfuric acid ammonia, (250~310nm, 10W) irradiation is 30 minutes for low pressure mercury lamp.After reaction finished, residue washed with ethyl acetate, the water concentrating under reduced pressure, and residue water-ethanol system recrystallization gets the 2.78g clear crystal, yield 80%.
This patent embodiment
Embodiment 1:
8.5L distilled water and 1.9kg L-halfcystine are mixed, a small amount of insolubles is arranged.Add the 2.2L vinylcarbinol, turbid solution is white in color.Finish, be heated to 50~60 ℃ of stirring reactions more than 7 hours.Stop to stir, in reaction solution, be added dropwise to 45L acetone, separate out white solid.Drip and finish, continue to stir 45 minutes, left standstill 0.5~1.0 hour, suction filtration gets white solid, with 3~5L acetone drip washing upper strata solid.The gained solid got 2.0kg product, yield 80% in 24 hours in 45 ℃ of dryings.
Embodiment 2:
4.3L distilled water and 1.0kg L-halfcystine are mixed, a small amount of insolubles is arranged.Add the 0.6L vinylcarbinol, turbid solution is white in color.Finish, be heated to 50~60 ℃ of stirring reactions more than 7 hours.Stop to stir, in reaction solution, be added dropwise to 23L acetone, separate out white solid.Drip and finish, continue to stir 45 minutes, left standstill 0.5~1.0 hour, suction filtration gets white solid, with 1~2L acetone drip washing upper strata solid.The gained solid got 0.9kg product, yield 70% in 24 hours in 45 ℃ of dryings.
Embodiment 3:
5.0L distilled water and 1.1kg L-halfcystine are mixed, a small amount of insolubles is arranged.Add the 1.3L vinylcarbinol, turbid solution is white in color.Finish, be heated to 70~80 ℃ of stirring reactions more than 7 hours.Stop to stir, in reaction solution, be added dropwise to 26L acetone, separate out white solid.Drip and finish, continue to stir 45 minutes, left standstill 0.5~1.0 hour, suction filtration gets white solid, with 2~3L acetone drip washing upper strata solid.The gained solid got 1.1kg product, yield 75% in 24 hours in 45 ℃ of dryings.

Claims (7)

1. preparation method as shown in the formula the Fudosteine shown in (I).
Formula (I)
Being characterized as of this method: with formula (II) compound
Figure A2005100597330002C2
Formula (II)
With compound shown in the formula (III)
Figure A2005100597330002C3
Formula (UI)
Under heating state, carry out addition reaction and obtain compound shown in the form (I).
2. claim 1 described method, wherein the reaction solvent of addition reaction is water, water-miscible organic solvent or its mixing solutions;
3. claim 1,2 described method, wherein the reaction solvent of addition reaction is a water;
4. claim 1,2,3 described methods, and wherein the temperature of reaction of addition reaction is 40~80 ℃;
5. the method that aforementioned any one claim requires, wherein the temperature of reaction of addition reaction is 50~60 ℃;
6. the method that aforementioned any one claim requires, wherein compound (I) is 1: 1 to 1: 3 with the mol ratio of compound (II).
7. the method that aforementioned any one claim requires, compound (I) is 1: 2 with the mol ratio of compound (II).
CN 200510059733 2005-03-31 2005-03-31 A kind of preparation method of Fudosteine Active CN100543014C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510059733 CN100543014C (en) 2005-03-31 2005-03-31 A kind of preparation method of Fudosteine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510059733 CN100543014C (en) 2005-03-31 2005-03-31 A kind of preparation method of Fudosteine

Publications (2)

Publication Number Publication Date
CN1840524A true CN1840524A (en) 2006-10-04
CN100543014C CN100543014C (en) 2009-09-23

Family

ID=37029749

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510059733 Active CN100543014C (en) 2005-03-31 2005-03-31 A kind of preparation method of Fudosteine

Country Status (1)

Country Link
CN (1) CN100543014C (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101717356A (en) * 2009-12-16 2010-06-02 天津工业大学 Method for microwave synthesis of a phlegm eliminating drug Fuduositan
CN101851185A (en) * 2009-10-20 2010-10-06 西华大学 Preparation and purification method of fudosteine
CN102060958A (en) * 2010-11-11 2011-05-18 天津工业大学 Method for preparing fudosteine molecularly imprinted polymer
CN103113273A (en) * 2013-02-01 2013-05-22 浙江国邦药业有限公司 Fudosteine synthesis method
CN103382171A (en) * 2013-07-22 2013-11-06 江苏万特制药有限公司 Preparing method of Fudosteine oxidation impurities
CN103739526A (en) * 2013-12-06 2014-04-23 迪沙药业集团山东迪沙药业有限公司 Fudosteine oxide impurity and preparation method thereof
CN104326954A (en) * 2014-10-17 2015-02-04 宜昌长江药业有限公司 Synthesis method of fudosteine
CN105622474A (en) * 2016-01-12 2016-06-01 安徽悦康凯悦制药有限公司 Production technique of fudosteine
CN105777595A (en) * 2016-04-23 2016-07-20 威海迪素制药有限公司 Preparation method of fodor stanozolol suitable for industrialized production
CN108358820A (en) * 2018-01-17 2018-08-03 威海迪素制药有限公司 A kind of preparation method of high-quality Fudosteine bulk pharmaceutical chemicals

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101851185A (en) * 2009-10-20 2010-10-06 西华大学 Preparation and purification method of fudosteine
CN101717356A (en) * 2009-12-16 2010-06-02 天津工业大学 Method for microwave synthesis of a phlegm eliminating drug Fuduositan
CN102060958A (en) * 2010-11-11 2011-05-18 天津工业大学 Method for preparing fudosteine molecularly imprinted polymer
CN102060958B (en) * 2010-11-11 2013-01-02 天津工业大学 Method for preparing fudosteine molecularly imprinted polymer
CN103113273B (en) * 2013-02-01 2014-09-10 浙江国邦药业有限公司 Fudosteine synthesis method
CN103113273A (en) * 2013-02-01 2013-05-22 浙江国邦药业有限公司 Fudosteine synthesis method
CN103382171A (en) * 2013-07-22 2013-11-06 江苏万特制药有限公司 Preparing method of Fudosteine oxidation impurities
CN103739526B (en) * 2013-12-06 2017-01-18 迪沙药业集团有限公司 Fudosteine oxide impurity and preparation method thereof
CN103739526A (en) * 2013-12-06 2014-04-23 迪沙药业集团山东迪沙药业有限公司 Fudosteine oxide impurity and preparation method thereof
CN104326954A (en) * 2014-10-17 2015-02-04 宜昌长江药业有限公司 Synthesis method of fudosteine
CN104326954B (en) * 2014-10-17 2016-03-30 宜昌东阳光长江药业股份有限公司 A kind of synthetic method of Fudosteine
CN105622474A (en) * 2016-01-12 2016-06-01 安徽悦康凯悦制药有限公司 Production technique of fudosteine
CN105777595A (en) * 2016-04-23 2016-07-20 威海迪素制药有限公司 Preparation method of fodor stanozolol suitable for industrialized production
CN105777595B (en) * 2016-04-23 2018-03-27 威海迪素制药有限公司 A kind of Fudosteine preparation method of suitable industrialized production
CN108358820A (en) * 2018-01-17 2018-08-03 威海迪素制药有限公司 A kind of preparation method of high-quality Fudosteine bulk pharmaceutical chemicals
CN108358820B (en) * 2018-01-17 2021-09-03 迪嘉药业集团有限公司 Preparation method of high-quality fudosteine raw material medicine

Also Published As

Publication number Publication date
CN100543014C (en) 2009-09-23

Similar Documents

Publication Publication Date Title
CN1840524A (en) Process for preparing fudosteine
CN1817862A (en) Production of pyriphenanthrenone as anti-fibrosis medicine
JP7297794B2 (en) Method for preparing keto-functionalized aromatic (meth)acrylates
US20220204529A1 (en) Method for preparing lornoxicam
CN102285911A (en) Method for preparing felodipine
WO2021114893A1 (en) Method for preparing 5-acetyl acetylaminobenzimidazolone
CN102229581A (en) Preparation method for febuxostat intermediate
CN104327129A (en) Method for preparing glucosamine hydrochloride by taking crab shells as raw materials
CN105085362A (en) Preparing method for high-purity crystal type atorvastatin calcium
CN101050206A (en) Method for preparing Repaglinide
CN1226295C (en) Synthesis of Important intermediate for mosapride citrate
CN102442944B (en) Preparation method of flunixin
CN109796414B (en) Method for continuously preparing rosuvastatin intermediate by adopting micro-channel modular reaction device
CN1687054A (en) Method for preparing compound of luteolin
CN1891684A (en) Method for preparing high-purity gahapentin
CN1566075A (en) Preparation method for substituted symmetrel compounds or salt thereof
CN1190422C (en) Prepn process of nifedipine
WO2022127410A1 (en) Catalyst, preparation method therefor, and use thereof in preparation of 4-hydroxy-2,2,6,6-tetramethyl-piperidinooxy
CN103965042B (en) A kind of synthetic method of ethoxy ethyl acrylate
CN1142159C (en) Prearation method of [(substituted pyridyl) methyl] sulfinyl-IH-benzimidazole compound magnesium salt
CN1290822C (en) Process for preparing gabapentin
CN110357773A (en) The synthesis of 3- chloro-4-hydroxyl benzoic acid
CN110963946A (en) Preparation method of sodium methyl taurate
CN1061985C (en) Method for preparation of progestol by degradation of steroidal saponin
RU2457838C1 (en) Method of obtaining trans-1,2-diaminocyclohexane tetrachloroplatinum (iv)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: VENTURE PHARMACEUTICAL (HAINAN) CO., LTD.

Free format text: FORMER OWNER: BEIJING D-VENTURE PHARM. T. CORP.

Effective date: 20120525

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100089 HAIDIAN, BEIJING TO: 570314 HAIKOU, HAINAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20120525

Address after: 570314 Nanhai Avenue, Hainan, Haikou, China, No. 279

Patentee after: Beijing D-Venturepharm Technology Development Co., Ltd.

Address before: 100089 Beijing city Haidian District Sijiqing Wanquan Zhuang 3 Building

Patentee before: Beijing D-Venture Pharm. T. Corp.